A diminutive protein prompts a closer look at DNA dark matter.

The head of Public Affairs for the Novartis Malaria Initiative has a malaria story of her own to tell.

Among the many Syrians uprooted by armed conflict are thousands of people with chronic conditions – such as diabetes and heart disease - whose treatment was disrupted when they fled.

Our Global Head of Precision Medicine in Oncology discusses her day-to-day work at Novartis.

Novartis is taming nuclear power and putting it to use to treat advanced cancer.

Spinal muscular atrophy (SMA) is the most common genetic casue of infant and toddler death. NIBR scientists are trying to make a back up gene take up the slack.

With external help from Novartis, an Argentinian researcher was able to begin his search for a new medicine for tuberculosis.

Jennifer Leeds offers a behind-the-scenes look at the consortia forming to address COVID-19.

Functional genomics study reveals a potential approach for tackling glioblastoma, pancreatic cancer and other tumors.

For over 60 years Novartis has been committed to helping people with cardiovascular disease and we remain steadfast in that commitment to this day.